News and reflections from the world of AI

    Interview with Emilian Gheorghe on using AI models for breast cancer grading

    While breast cancer is a leading cause of cancer death in women worldwide, current approaches for diagnosis and therapy are in need of an upgrade. ...
    Written by Aiforia

    Doctoral student Polina Stepanova discusses benefits of AI in Huntington's Disease image analysis

    What is Huntington's Disease? Huntington's disease (HD) is a progressive brain disorder caused by a single defective gene, called huntingtin. Over ...
    Written by Aiforia

    Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

    Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing ...
    Written by Aiforia
    June 10, 2021

    Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

    First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia™ Clinical AI Model for Breast Cancer: Ki67, a widely used key biomarker in breast cancer diagnostics across pathology labs around the world. The AI Model is able to calculate Ki67 positive and negative cells specifically in invasive areas of human breast tissue in whole slide images (WSI) as well as in ...
    Written by Aiforia
    June 3, 2021

    Aiforia Raises €12.6M in Series B Funding to Enhance Precision Diagnostics and Preclinical Analysis in Pathology

    Helsinki – June 3, 2021 - Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology, announced today the closing of the first €12.6M tranche of their Series B round. The funding round has the potential to reach €25.2M if investors exercise the optional second tranche. The funding round is led by Epredia's UK entity, a subsidiary of PHC ...
    Written by Aiforia
    April 8, 2021

    New Finnish consortium aims to enhance diagnostics and combat pandemics

    The COVID-19 pandemic has highlighted the importance of efficient diagnostic methods. Beyond battling pandemics, there are also significant diagnostic needs in everyday healthcare but healthcare systems around the world are struggling with rapidly increasing costs. The Future of Diagnostics (FUDIS) co-innovation consortium was created to address these challenges — to develop reliable, rapid, ...
    Written by Aiforia
    1 2 3 4